|
GDAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.598000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.486000E-02 |
| Normal-vs-Stage2 |
2.969200E-01 |
| Normal-vs-Stage3 |
1.218380E-01 |
| Normal-vs-Stage4 |
4.579200E-01 |
| Stage1-vs-Stage2 |
5.773400E-01 |
| Stage1-vs-Stage3 |
5.435300E-03 |
| Stage1-vs-Stage4 |
5.524400E-01 |
| Stage2-vs-Stage3 |
5.650200E-02 |
| Stage2-vs-Stage4 |
9.053800E-01 |
| Stage3-vs-Stage4 |
1.636390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.497000E-01 |
| Normal-vs-AfricanAmerican |
6.352300E-02 |
| Normal-vs-Asian |
7.026400E-01 |
| Caucasian-vs-AfricanAmerican |
1.796950E-01 |
| Caucasian-vs-Asian |
3.293800E-01 |
| AfricanAmerican-vs-Asian |
1.590650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.109500E-02 |
| Normal-vs-Female |
1.871830E-01 |
| Male-vs-Female |
1.812360E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.295000E-01 |
| Normal-vs-Extreme_Weight |
1.199660E-02 |
| Normal-vs-Obese |
9.793000E-01 |
| Normal-vs-Extreme_Obese |
1.578420E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.102190E-01 |
| Normal_Weight-vs-Obese |
6.450400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.666800E-01 |
| Extreme_Weight-vs-Obese |
2.186500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.811200E-01 |
| Obese-vs-Extreme_Obese |
3.426400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.609030E-01 |
| Normal-vs-Age(41-60Yrs) |
4.323600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.894400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.451800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.941800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.168300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.970100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.852200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.333000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.206000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.799700E-02 |
| Normal-VS-Type2 PRCC |
3.311800E-01 |
| Normal-VS-KIRP CIMP |
7.185500E-02 |
| Normal-VS-Unclassified PRCC |
5.767600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.187400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.519700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.527990E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.492300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.902010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.031980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.849860E-02 |
| Normal-vs-N1 |
4.909600E-02 |
| Normal-vs-N2 |
2.348600E-01 |
| N0-vs-N1 |
2.943200E-03 |
| N0-vs-N2 |
8.710800E-01 |
| N1-vs-N2 |
1.654550E-01 |
|
|
